|
Friday, May 13, 2022, New Orleans, Louisiana, 6:00 PM – 8:00 PM Central Time (7:00 PM – 9:00 PM Eastern Time)
Cases from the Community: Urologic Oncology Investigators Provide Perspectives on the Optimal Management of Urothelial Bladder CancerPart 2 of a 2-Part CME Satellite Symposium Series in Conjunction with the American Urological Association (AUA) 2022 Annual Meeting
Location
New Orleans Ernest N Morial Convention Center 900 Convention Center Blvd New Orleans, LA 70130 Phone: (504) 582-3000 Program Schedule — Central Time 5:30 PM – 6:00 PM — Registration 6:00 PM – 8:00 PM — Dinner Meeting Meeting Room Rooms 265-268 (Second Floor) This event will also be webcast live. Please see Registration tab for details. Faculty
Matthew D Galsky, MD Professor of Medicine Icahn School of Medicine at Mount Sinai Co-Leader, Bladder Cancer Center of Excellence Associate Director, Translational Research The Tisch Cancer Institute New York, New York Ashish M Kamat, MD, MBBS Professor of Urologic Oncology (Surgery) Wayne B Duddlesten Professor of Cancer Research Department of Urology Division of Surgery The University of Texas MD Anderson Cancer Center Houston, Texas Stephen B Williams, MD, MS Medical Director, High Value Care UTMB Health System Chief, Division of Urology Professor (Tenured), Urology and Radiology Robert Earl Cone Professorship Director of Urologic Oncology Director of Urologic Research Co-Director of the Surgical Outcomes Research Division The University of Texas Medical Branch Galveston, Texas Moderator Sumanta Kumar Pal, MD Professor, Department of Medical Oncology and Therapeutics Research City of Hope Duarte, California This activity is supported by educational grants from Astellas and Seagen Inc, AstraZeneca Pharmaceuticals LP, Gilead Sciences Inc, and Janssen Biotech Inc, administered by Janssen Scientific Affairs LLC.
Program Schedule — Central Time 5:30 PM – 6:00 PM — Registration 6:00 PM – 8:00 PM — Educational Dinner Meeting MODULE 1: Available Data with and Ongoing Investigation of Novel Agents and Strategies for Non-Muscle-Invasive Bladder Cancer (NMIBC) — Dr Kamat
MODULE 2: Novel Therapeutic Approaches for Muscle-Invasive Bladder Cancer (MIBC) — Dr Williams
MODULE 3: Current and Future Front-Line Management of Metastatic Urothelial Bladder Carcinoma (mUBC) — Dr Galsky
MODULE 4: Selection and Sequencing of Therapy for Relapsed/Refractory mUBC — Dr Pal
Target Audience
CME Credit Form FACULTY — Dr Kamat and Dr Williams have no relevant conflicts of interest to disclose. The following faculty reported relevant financial relationships with ineligible entities: Dr Galsky — Advisory Committee: Aileron Therapeutics Inc, Alligator Bioscience, Astellas, AstraZeneca Pharmaceuticals LP, Basilea Pharmaceutica Ltd, BioMotiv, Bristol-Myers Squibb Company, Dendreon Pharmaceuticals Inc, Dracen Pharmaceuticals, Dragonfly Therapeutics, EMD Serono Inc, Genentech, a member of the Roche Group, Gilead Sciences Inc, GlaxoSmithKline, Incyte Corporation, Infinity Pharmaceuticals Inc, Inovio Pharmaceuticals Inc, Janssen Biotech Inc, Lilly, Merck, Novartis, Numab, Pfizer Inc, Seagen Inc, UroGen Pharma; Contracted Research: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Genentech, a member of the Roche Group, Merck.MODERATOR — Dr Pal has no relevant conflicts of interest to disclose. RESEARCH TO PRACTICE PRESIDENT NEIL LOVE, MD — Dr Love is president and CEO of Research To Practice. Research To Practice receives funds in the form of educational grants to develop CME activities from the following companies: AbbVie Inc, Adaptive Biotechnologies Corporation, ADC Therapeutics, Agios Pharmaceuticals Inc, Alexion Pharmaceuticals, Amgen Inc, Array BioPharma Inc, a subsidiary of Pfizer Inc, Astellas, AstraZeneca Pharmaceuticals LP, Aveo Pharmaceuticals, Bayer HealthCare Pharmaceuticals, BeiGene Ltd, BeyondSpring Pharmaceuticals Inc, Blueprint Medicines, Boehringer Ingelheim Pharmaceuticals Inc, Bristol-Myers Squibb Company, Celgene Corporation, Clovis Oncology, Coherus BioSciences, CTI BioPharma Corp, Daiichi Sankyo Inc, Eisai Inc, Elevation Oncology Inc, EMD Serono Inc, Epizyme Inc, Exact Sciences, Exelixis Inc, Five Prime Therapeutics Inc, Foundation Medicine, G1 Therapeutics Inc, Genentech, a member of the Roche Group, Genmab, Gilead Sciences Inc, GlaxoSmithKline, Grail Inc, Halozyme Inc, Helsinn Healthcare SA, ImmunoGen Inc, Incyte Corporation, Ipsen Biopharmaceuticals Inc, Janssen Biotech Inc, administered by Janssen Scientific Affairs LLC, Jazz Pharmaceuticals Inc, Karyopharm Therapeutics, Kite, A Gilead Company, Lilly, Loxo Oncology Inc, a wholly owned subsidiary of Eli Lilly & Company, Merck, Mersana Therapeutics Inc, Natera Inc, Novartis, Novartis Pharmaceuticals Corporation on behalf of Advanced Accelerator Applications, Novocure Inc, Oncopeptides, Pfizer Inc, Pharmacyclics LLC, an AbbVie Company, Puma Biotechnology Inc, Regeneron Pharmaceuticals Inc, Sanofi Genzyme, Seagen Inc, Servier Pharmaceuticals LLC, Sumitomo Dainippon Pharma Oncology Inc, Taiho Oncology Inc, Takeda Pharmaceuticals USA Inc, Tesaro, A GSK Company, TG Therapeutics Inc, Turning Point Therapeutics Inc, Verastem Inc and Zymeworks Inc. RESEARCH TO PRACTICE CME PLANNING COMMITTEE MEMBERS, STAFF AND REVIEWERS — Planners, scientific staff and independent reviewers for Research To Practice have no relevant conflicts of interest to disclose. SupportersThis activity is supported by educational grants from Astellas and Seagen Inc, AstraZeneca Pharmaceuticals LP, Gilead Sciences Inc, and Janssen Biotech Inc, administered by Janssen Scientific Affairs LLC. New Orleans Ernest N Morial Convention Center Thank you for your interest in our CME program. At this time online preregistration is closed for in-person participants. SEATS ARE STILL AVAILABLE FOR THE SESSION. Our Onsite Registration Desk will be open at 5:15 PM Central Time on Friday, May 13th. If you are interested in attending, please visit our onsite registration desk located outside Meetings Rooms 265-268 (Second Floor) of the New Orleans Ernest N Morial Convention Center (900 Convention Center Blvd). If you have any questions, please feel free to contact us via email at Meetings@ResearchToPractice.com, or call (800) 233-6153. There is no fee for participation in this event. Registration for live webcast
Please note we will stream this event over Zoom. After registering you will receive a separate confirmation from Zoom with the viewing instructions. REGISTRATION FOR WEBCAST »Registration for groups
If you are registering a group (more than 1 person) for this event, please contact us at
Meetings@ResearchToPractice.com or (800) 233-6153.
To ensure seating and meal service, please check in at our onsite registration desk at least 30 minutes before the start of the meeting. We cannot guarantee seating after the start of the program.Photography and/or video recording may be taken during the educational program by Research To Practice and used in future educational offerings. Research To Practice fully complies with the legal requirements of the ADA. If you are in need of assistance (ie, physical, dietary, et cetera), please contact us prior to the event at (800) 233-6153.
|